XNAS 05 May, 2026 10:03 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2026 | 14,722 | 75,160 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2026 | 14,722 | 89,882 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 22 Apr 2026 | 19,060 | 382,132 (0%) | 0% | 14.0 | 267,221 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Apr 2026 | 14,722 | 401,192 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 22 Apr 2026 | 19,060 | 386,470 (0%) | 0% | 13.7 | 261,884 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Apr 2026 | 14,722 | 405,530 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.13 per share. | 22 Apr 2026 | 19,060 | 390,808 (0%) | 0% | 14.1 | 269,318 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Apr 2026 | 14,722 | 409,868 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2026 | 14,722 | 60,438 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 17 Apr 2026 | 19,060 | 399,484 (0%) | 0% | 14.6 | 277,323 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 17 Apr 2026 | 14,722 | 414,206 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 17 Apr 2026 | 11,881 | 426,087 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.66 per share. | 17 Apr 2026 | 30,941 | 395,146 (0%) | 0% | 14.7 | 453,595 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2026 | 14,722 | 134,048 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2026 | 14,722 | 119,326 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2026 | 14,722 | 104,604 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2026 | 11,881 | 379,777 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.57 per share. | 17 Apr 2026 | 19,060 | 403,822 (0%) | 0% | 14.6 | 277,704 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 17 Apr 2026 | 14,722 | 418,544 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 17 Apr 2026 | 14,722 | 422,882 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 14 Apr 2026 | 14,722 | 435,896 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 14,722 | 148,770 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 14,722 | 163,492 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2026 | 14,722 | 178,214 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.18 per share. | 14 Apr 2026 | 19,060 | 408,160 (0%) | 0% | 14.2 | 270,271 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 14 Apr 2026 | 14,722 | 427,220 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.61 per share. | 14 Apr 2026 | 19,060 | 412,498 (0%) | 0% | 14.6 | 278,467 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 14 Apr 2026 | 14,722 | 431,558 (0%) | 0% | 8.5 | 124,548 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 14 Apr 2026 | 19,060 | 416,836 (0%) | 0% | 14.6 | 277,514 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 14,722 | 448,910 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 6,613 | 192,936 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 8,109 | 0 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 14,722 | 8,109 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 14,722 | 22,831 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 09 Apr 2026 | 3,338 | 421,174 (0%) | 0% | 14.1 | 46,999 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.95 per share. | 09 Apr 2026 | 15,722 | 424,512 (0%) | 0% | 13.0 | 203,600 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 09 Apr 2026 | 6,613 | 440,234 (0%) | 0% | 8.5 | 55,946 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 8,109 | 433,621 (0%) | 0% | 7.3 | 58,952 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 09 Apr 2026 | 400 | 425,512 (0%) | 0% | 13.5 | 5,392 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 09 Apr 2026 | 18,660 | 425,912 (0%) | 0% | 12.8 | 237,915 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Apr 2026 | 14,722 | 444,572 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.44 per share. | 09 Apr 2026 | 2,100 | 429,850 (0%) | 0% | 14.4 | 30,324 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 09 Apr 2026 | 16,960 | 431,950 (0%) | 0% | 13.8 | 233,878 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 08 Apr 2026 | 10,000 | 1,512,058 (1%) | 0% | 14.9 | 148,500 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 2,344 | 88,297 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Apr 2026 | 22,564 | 271,154 (0%) | 0% | 15.1 | 340,039 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 08 Apr 2026 | 2,344 | 293,718 (0%) | 0% | 4.0 | 9,353 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 14.41 per share. | 06 Apr 2026 | 83,332 | 2,217,781 (1%) | 0% | 14.4 | 1,200,814 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 06 Apr 2026 | 37,263 | 2,180,518 (1%) | 0% | 15.2 | 566,025 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 06 Apr 2026 | 14,722 | 461,924 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.33 per share. | 06 Apr 2026 | 19,060 | 442,864 (0%) | 0% | 14.3 | 273,130 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 06 Apr 2026 | 14,722 | 457,586 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.56 per share. | 06 Apr 2026 | 19,060 | 438,526 (0%) | 0% | 13.6 | 258,454 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 06 Apr 2026 | 14,722 | 453,248 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 06 Apr 2026 | 11,881 | 465,129 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 06 Apr 2026 | 30,841 | 434,288 (0%) | 0% | 14.8 | 457,372 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 15.48 per share. | 06 Apr 2026 | 100 | 434,188 (0%) | 0% | 15.5 | 1,548 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 14,722 | 66,997 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 14,722 | 52,275 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 14,722 | 37,553 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 11,881 | 391,658 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 01 Apr 2026 | 14,722 | 466,262 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 01 Apr 2026 | 19,060 | 451,540 (0%) | 0% | 14.5 | 275,417 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 01 Apr 2026 | 14,722 | 470,600 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 14,722 | 81,719 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 14,722 | 96,441 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 01 Apr 2026 | 19,060 | 447,202 (0%) | 0% | 14.6 | 278,276 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 27 Mar 2026 | 14,722 | 483,614 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2026 | 14,722 | 111,163 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2026 | 14,722 | 125,885 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2026 | 14,722 | 140,607 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 27 Mar 2026 | 19,060 | 455,878 (0%) | 0% | 13.5 | 256,357 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 27 Mar 2026 | 14,722 | 474,938 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.63 per share. | 27 Mar 2026 | 19,060 | 460,216 (0%) | 0% | 12.6 | 240,728 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 27 Mar 2026 | 14,722 | 479,276 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 27 Mar 2026 | 16,322 | 464,554 (0%) | 0% | 13.5 | 220,021 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.49 per share. | 27 Mar 2026 | 2,738 | 480,876 (0%) | 0% | 12.5 | 34,198 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 14,722 | 184,773 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.12 per share. | 24 Mar 2026 | 19,060 | 468,892 (0%) | 0% | 14.1 | 269,127 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 24 Mar 2026 | 14,722 | 487,952 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.27 per share. | 24 Mar 2026 | 19,060 | 473,230 (0%) | 0% | 14.3 | 271,986 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 24 Mar 2026 | 14,722 | 492,290 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.70 per share. | 24 Mar 2026 | 19,060 | 477,568 (0%) | 0% | 13.7 | 261,122 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 24 Mar 2026 | 14,722 | 496,628 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 14,722 | 155,329 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 14,722 | 170,051 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Mar 2026 | 14,722 | 509,642 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 14,722 | 199,495 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 10,783 | 214,217 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 3,939 | 0 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 14,722 | 3,939 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.83 per share. | 19 Mar 2026 | 19,060 | 481,906 (0%) | 0% | 13.8 | 263,600 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 19 Mar 2026 | 14,722 | 500,966 (0%) | 0% | 7.3 | 107,029 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.37 per share. | 19 Mar 2026 | 19,060 | 486,244 (0%) | 0% | 13.4 | 254,832 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 19 Mar 2026 | 10,783 | 505,304 (0%) | 0% | 7.3 | 78,392 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Mar 2026 | 3,939 | 494,521 (0%) | 0% | 6.5 | 25,800 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.18 per share. | 19 Mar 2026 | 19,060 | 490,582 (0%) | 0% | 13.2 | 251,211 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 16 Mar 2026 | 14,722 | 522,656 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 14,722 | 18,661 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 14,722 | 33,383 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 14,722 | 48,105 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.18 per share. | 16 Mar 2026 | 19,060 | 494,920 (0%) | 0% | 13.2 | 251,211 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 16 Mar 2026 | 14,722 | 513,980 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.40 per share. | 16 Mar 2026 | 19,060 | 499,258 (0%) | 0% | 13.4 | 255,404 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 16 Mar 2026 | 14,722 | 518,318 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 16 Mar 2026 | 19,060 | 503,596 (0%) | 0% | 13.4 | 255,595 | Common Stock |
| Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 13.91 per share. | 11 Mar 2026 | 15,394 | 15,625 (0%) | 0% | 13.9 | 214,131 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 140,567 | 2,630,713 (2%) | 0% | 13.2 | 1,851,267 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 329,600 | 2,301,113 (1%) | 0% | 13.2 | 4,340,832 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 14,722 | 92,271 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.96 per share. | 11 Mar 2026 | 19,060 | 507,934 (0%) | 0% | 13.0 | 247,018 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 11 Mar 2026 | 14,722 | 526,994 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 11 Mar 2026 | 5,400 | 512,272 (0%) | 0% | 13.4 | 72,522 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 12.63 per share. | 11 Mar 2026 | 13,660 | 517,672 (0%) | 0% | 12.6 | 172,526 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 11 Mar 2026 | 14,722 | 531,332 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 11 Mar 2026 | 19,060 | 516,610 (0%) | 0% | 14.1 | 268,365 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 122,523 | 520,948 (0%) | 0% | 13.2 | 1,613,628 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 11 Mar 2026 | 14,722 | 535,670 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 14,722 | 62,827 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 14,722 | 77,549 | - | - | Stock Option (right to buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 140,666 | 1,851,658 (1%) | 0% | 13.2 | 1,852,571 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 329,600 | 1,522,058 (1%) | 0% | 13.2 | 4,340,832 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 11 Mar 2026 | 30,593 | 291,374 (0%) | 0% | 14.1 | 430,749 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 63,103 | 272,751 (0%) | 0% | 13.2 | 831,067 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 18,672 | 259,840 (0%) | 0% | 13.2 | 245,910 | Common Stock |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 41,338 | 427,775 (0%) | 0% | 13.2 | 544,421 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 11,881 | 415,820 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 14,722 | 136,437 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.68 per share. | 06 Mar 2026 | 19,460 | 643,471 (0%) | 0% | 14.7 | 285,673 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 06 Mar 2026 | 400 | 662,931 (0%) | 0% | 12.1 | 4,856 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 06 Mar 2026 | 14,722 | 662,531 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 14.79 per share. | 06 Mar 2026 | 30,941 | 647,809 (0%) | 0% | 14.8 | 457,617 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 06 Mar 2026 | 11,881 | 678,750 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 06 Mar 2026 | 14,722 | 666,869 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 06 Mar 2026 | 30,941 | 652,147 (0%) | 0% | 15.1 | 468,447 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 06 Mar 2026 | 11,881 | 683,088 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 06 Mar 2026 | 14,722 | 671,207 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 400 | 403,539 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 14,722 | 106,993 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 11,881 | 403,939 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 14,722 | 121,715 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 05 Mar 2026 | 38,074 | 321,967 (0%) | 0% | 15.1 | 574,537 | Common Stock |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 240,315 (0%) | 0% | 0 | Common Stock | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 62,347 (0%) | 0% | 0 | Common Stock | |
| Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 31,019 (0%) | 0% | 0 | Common Stock | |
| Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 127,813 | 2,062,060 (1%) | 0% | 0 | Common Stock | |
| Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 709,220 | 2,771,280 (2%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 81,250 | 656,485 (0%) | 0% | 0 | Common Stock | |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 709,220 | 1,992,324 (1%) | 0% | 0 | Common Stock | |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 127,813 | 1,283,104 (1%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 44,063 | 360,041 (0%) | 0% | 0 | Common Stock | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 39,063 | 335,854 (0%) | 0% | 0 | Common Stock | |
| Kyle Piskel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 61,875 | 278,512 (0%) | 0% | 0 | Common Stock | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 59,375 | 406,613 (0%) | 0% | 0 | Common Stock | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 62,500 | 469,113 (0%) | 0% | 0 | Common Stock | |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 88,254 (0%) | 0% | 0 | Common Stock | |
| Michelle G. Burris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 48,044 | 0 | - | - | Stock Option (right to buy) | |
| Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 03 Mar 2026 | 48,044 | 15,394 (0%) | 0% | 15.3 | 735,073 | Common Stock |
| Michelle G. Burris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 03 Mar 2026 | 48,044 | 63,438 (0%) | 0% | 4.0 | 191,696 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 11,881 | 439,582 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 14,722 | 165,881 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 11,881 | 451,463 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 14,722 | 180,603 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 03 Mar 2026 | 30,941 | 575,235 (0%) | 0% | 16 | 495,056 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 03 Mar 2026 | 11,881 | 606,176 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 03 Mar 2026 | 14,722 | 594,295 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 16.60 per share. | 03 Mar 2026 | 30,941 | 579,573 (0%) | 0% | 16.6 | 513,621 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 03 Mar 2026 | 11,881 | 610,514 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 03 Mar 2026 | 14,722 | 598,633 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 03 Mar 2026 | 6,518 | 583,911 (0%) | 0% | 16.3 | 106,439 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 15.49 per share. | 03 Mar 2026 | 24,423 | 590,429 (0%) | 0% | 15.5 | 378,312 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 03 Mar 2026 | 14,722 | 602,971 (0%) | 0% | 6.5 | 96,429 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 03 Mar 2026 | 11,881 | 614,852 (0%) | 0% | 12.1 | 144,235 | Common Stock |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 11,881 | 427,701 | - | - | Stock Option (right to buy) | |
| Julie Rubinstein | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 14,722 | 151,159 | - | - | Stock Option (right to buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 02 Mar 2026 | 10,000 | 1,169,524 (0%) | 0% | 15.7 | 157,200 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 02 Mar 2026 | 14,233 | 1,155,291 (0%) | 0% | 16.5 | 235,129 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 16.15 per share. | 27 Feb 2026 | 2,380 | 1,934,247 (1%) | 0% | 16.2 | 38,437 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.49 per share. | 27 Feb 2026 | 50,703 | 1,936,627 (1%) | 0% | 15.5 | 785,389 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 27 Feb 2026 | 182,891 | 2,276,354 (1%) | 0% | 16.0 | 2,924,427 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 27 Feb 2026 | 289,024 | 1,987,330 (1%) | 0% | 15.8 | 4,572,360 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2026 | 2,145 | 2,146 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.46 per share. | 04 Feb 2026 | 2,145 | 216,637 (0%) | 0% | 18.5 | 39,597 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 04 Feb 2026 | 2,145 | 218,782 (0%) | 0% | 12.1 | 26,040 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 18.44 per share. | 02 Feb 2026 | 124,998 | 2,459,245 (1%) | 0% | 18.4 | 2,304,963 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 02 Feb 2026 | 8,120 | 1,179,524 (0%) | 0% | 19 | 154,280 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 02 Feb 2026 | 34,668 | 1,187,644 (0%) | 0% | 18.6 | 644,825 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 14,215 | 90,641 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 12 Jan 2026 | 36,650 | 352,628 (0%) | 0% | 7.8 | 285,870 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 12 Jan 2026 | 7,723 | 360,351 (0%) | 0% | 12.1 | 93,757 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 12 Jan 2026 | 21,002 | 381,353 (0%) | 0% | 8.5 | 177,677 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 12 Jan 2026 | 14,215 | 395,568 (0%) | 0% | 4.0 | 56,718 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.73 per share. | 12 Jan 2026 | 79,590 | 315,978 (0%) | 0% | 17.7 | 1,411,131 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 36,650 | 75,500 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 7,723 | 177,615 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 21,002 | 87,074 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 12 Jan 2026 | 4,290 | 220,927 (0%) | 0% | 12.1 | 52,081 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jan 2026 | 4,290 | 216,637 (0%) | 0% | 18 | 77,220 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 4,290 | 4,291 | - | - | Stock Option (right to buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.44 per share. | 06 Jan 2026 | 10,000 | 1,222,312 (0%) | 0% | 16.4 | 164,400 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.59 per share. | 05 Jan 2026 | 124,998 | 2,584,243 (2%) | 0% | 15.6 | 1,948,719 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 02 Jan 2026 | 3,125 | 319,103 (0%) | 0% | 4.0 | 12,469 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 02 Jan 2026 | 3,125 | 315,978 (0%) | 0% | 16.1 | 50,250 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 3,125 | 104,856 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 22 Dec 2025 | 1,100 | 317,078 (0%) | 0% | 7.8 | 8,580 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 2,194 | 106,982 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 109,075 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 112,150 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Dec 2025 | 4,394 | 315,978 (0%) | 0% | 17.5 | 76,895 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 22 Dec 2025 | 1,100 | 320,372 (0%) | 0% | 4.0 | 4,389 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Dec 2025 | 2,194 | 319,272 (0%) | 0% | 8.5 | 18,561 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 22 Dec 2025 | 1,100 | 317,078 (0%) | 0% | 7.8 | 8,580 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 108,076 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 2,194 | 107,981 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 112,150 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Dec 2025 | 4,394 | 315,978 (0%) | 0% | 17.5 | 76,895 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 22 Dec 2025 | 2,194 | 320,372 (0%) | 0% | 4.0 | 8,754 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Dec 2025 | 1,100 | 318,178 (0%) | 0% | 8.5 | 9,306 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 15 Dec 2025 | 37,750 | 370,596 (0%) | 0% | 7.8 | 294,450 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 39,849 | 110,175 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 19,423 | 109,176 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 37,750 | 113,250 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 15 Dec 2025 | 113,890 | 315,978 (0%) | 0% | 15.6 | 1,773,267 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 15 Dec 2025 | 39,849 | 429,868 (0%) | 0% | 4.0 | 158,998 | Common Stock |
| Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 15 Dec 2025 | 19,423 | 390,019 (0%) | 0% | 8.5 | 164,319 | Common Stock |
| Robert M. Hershberg | Director | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 10 Dec 2025 | 22,968 | 46,722 (0%) | 0% | 16 | 367,488 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 04 Dec 2025 | 4,290 | 301,081 (0%) | 0% | 12.1 | 52,081 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 4,157 | 112,247 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 4,157 | 62,360 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 4,290 | 12,871 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 16.85 per share. | 04 Dec 2025 | 12,604 | 296,791 (0%) | 0% | 16.8 | 212,377 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 04 Dec 2025 | 4,157 | 309,395 (0%) | 0% | 4.0 | 16,586 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 04 Dec 2025 | 4,157 | 305,238 (0%) | 0% | 8.5 | 35,168 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 03 Dec 2025 | 10,000 | 1,232,312 (0%) | 0% | 16.6 | 166,100 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 03 Dec 2025 | 27,212 | 1,242,312 (0%) | 0% | 18.6 | 506,415 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 28 Nov 2025 | 11,980 | 281,323 (0%) | 0% | 6.6 | 78,469 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 94,384 | 8,581 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 3,750 | 0 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2025 | 11,980 | 0 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 28 Nov 2025 | 162,820 | 216,637 (0%) | 0% | 19.5 | 3,174,990 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 28 Nov 2025 | 94,384 | 379,457 (0%) | 0% | 12.1 | 1,145,822 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 28 Nov 2025 | 3,750 | 285,073 (0%) | 0% | 7.8 | 29,250 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 18.94 per share. | 26 Nov 2025 | 124,998 | 2,709,241 (2%) | 0% | 18.9 | 2,367,462 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 26 Nov 2025 | 35,736 | 2,834,239 (2%) | 0% | 19.7 | 703,284 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 16.54 per share. | 20 Nov 2025 | 297,925 | 296,791 (0%) | 0% | 16.5 | 4,927,680 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 20 Nov 2025 | 119,809 | 522,123 (0%) | 0% | 12.1 | 1,454,481 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 20 Nov 2025 | 34,375 | 402,314 (0%) | 0% | 7.3 | 249,906 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 20 Nov 2025 | 49,480 | 367,939 (0%) | 0% | 6.6 | 324,094 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 20 Nov 2025 | 20,834 | 318,459 (0%) | 0% | 6.6 | 136,463 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 20 Nov 2025 | 133,032 | 525,755 (0%) | 0% | 8.5 | 1,125,451 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 119,809 | 17,161 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 83,145 | 116,404 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 20 Nov 2025 | 68,961 | 594,716 (0%) | 0% | 12.1 | 837,187 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.27 per share. | 20 Nov 2025 | 834 | 297,625 (0%) | 0% | 6.3 | 5,229 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 34,375 | 0 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 49,480 | 0 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,834 | 0 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 834 | 0 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 68,961 | 136,970 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 133,032 | 66,517 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 20 Nov 2025 | 308,477 | 296,791 (0%) | 0% | 16.9 | 5,216,346 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 20 Nov 2025 | 83,145 | 605,268 (0%) | 0% | 4.0 | 331,749 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.05 per share. | 17 Nov 2025 | 238 | 269,343 (0%) | 0% | 14.1 | 3,344 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 10 Nov 2025 | 1,867 | 2,869,975 (2%) | 0% | 15 | 28,005 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 14.57 per share. | 10 Nov 2025 | 1,237 | 2,871,851 (2%) | 0% | 14.6 | 18,023 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 10 Nov 2025 | 86,161 | 2,873,088 (2%) | 0% | 14.7 | 1,269,152 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 10 Nov 2025 | 10,000 | 1,269,524 (1%) | 0% | 14.8 | 148,200 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 16 May 2025 | 1,929 | 269,581 (0%) | 0% | 8.9 | 17,149 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 15 May 2025 | 1,929 | 277,396 (0%) | 0% | 8.9 | 17,149 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 7,815 | 279,325 (0%) | 0% | 0 | Common Stock | |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 68,412 | 0 | - | - | Stock Option (Right to Buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.35 per share. | 01 May 2025 | 68,412 | 1,279,524 (1%) | 0% | 7.3 | 502,828 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 01 May 2025 | 68,412 | 1,347,936 (1%) | 0% | 6.3 | 432,364 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 24 Mar 2025 | 1,698 | 1,281,222 (1%) | 0% | 6.3 | 10,731 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 24 Mar 2025 | 1,698 | 1,279,524 (1%) | 0% | 9 | 15,282 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 1,698 | 68,412 | - | - | Stock Option (Right to Buy) | |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 14 Mar 2025 | 2,500 | 271,510 (0%) | 0% | 6.3 | 15,800 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.19 per share. | 13 Mar 2025 | 36,291 | 15,394 (0%) | 0% | 7.2 | 260,932 | Common Stock |
| Robert M. Hershberg | Director | Sale of securities on an exchange or to another person at price $ 7.59 per share. | 12 Mar 2025 | 53,000 | 69,690 (0%) | 0% | 7.6 | 402,270 | Common Stock |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Peter M. Neupert | Director | Sale of securities on an exchange or to another person at price $ 7.05 per share. | 10 Mar 2025 | 10,000 | 224,690 (0%) | 0% | 7.1 | 70,500 | Common Stock |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.07 per share. | 10 Mar 2025 | 50,000 | 234,690 (0%) | 0% | 4.1 | 203,500 | Common Stock |
| Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 69,690 (0%) | 0% | 0 | Common Stock | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 184,690 (0%) | 0% | 0 | Common Stock | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 122,690 (0%) | 0% | 0 | Common Stock | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 04 Mar 2025 | 15,664 | 51,685 (0%) | 0% | 7.9 | 124,372 | Common Stock |
| Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 67,349 (0%) | 0% | 0 | Common Stock | |
| Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 2,931,701 (2%) | 0% | 0 | Common Stock | |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 04 Mar 2025 | 102,218 | 2,959,249 (2%) | 0% | 7.6 | 780,946 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 247,117 | 3,061,467 (2%) | 0% | 0 | Common Stock | |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 36,145 | 2,814,350 (2%) | 0% | 7.0 | 252,654 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 81,206 | 2,850,495 (2%) | 0% | 7.0 | 566,818 | Common Stock |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,044 | 607,710 (0%) | 0% | 7.0 | 279,507 | Common Stock |
| Julie Rubinstein | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 175,000 | 647,754 (0%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 19,461 | 588,249 (0%) | 0% | 7.0 | 136,032 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 1,376,180 (1%) | 0% | 0 | Common Stock | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,603 | 1,335,577 (1%) | 0% | 7.0 | 283,409 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 56,053 | 1,279,524 (1%) | 0% | 7.0 | 391,810 | Common Stock |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 99,976 | 353,721 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 7,085 | 346,636 (0%) | 0% | 7.0 | 49,453 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 13,790 | 332,846 (0%) | 0% | 7.0 | 96,392 | Common Stock |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 109,973 | 437,388 (0%) | 0% | 0 | Common Stock | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 41,600 | 395,788 (0%) | 0% | 7.0 | 290,368 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 3,065 | 392,723 (0%) | 0% | 7.0 | 21,424 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 165,027 | 165,027 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 6,964 | 269,010 (0%) | 0% | 7.0 | 48,678 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 253 | 275,974 (0%) | 0% | 7.0 | 1,766 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.97 per share. | 04 Mar 2025 | 3,103 | 276,227 (0%) | 0% | 7.0 | 21,628 | Common Stock |
| Kyle Piskel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 125,000 | 279,330 (0%) | 0% | 0 | Common Stock | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 119,971 | 373,261 (0%) | 0% | 0 | Common Stock | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 180,029 | 180,029 | - | - | Stock Option (right to buy) | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 26,023 | 347,238 (0%) | 0% | 7.0 | 181,641 | Common Stock |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 72,629 (0%) | 0% | 0 | Common Stock | |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 19 Feb 2025 | 186,080 | 2,762,781 (2%) | 0% | 6.3 | 1,176,026 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 19 Feb 2025 | 186,080 | 2,576,701 (2%) | 0% | 8.5 | 1,574,237 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 19 Feb 2025 | 99,107 | 2,675,808 (2%) | 0% | 6.3 | 626,356 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 19 Feb 2025 | 99,107 | 2,576,701 (2%) | 0% | 8.4 | 836,463 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 186,080 | 99,107 | - | - | Stock Option (right to buy) | |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 99,107 | 0 | - | - | Stock Option (right to buy) | |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Feb 2025 | 100,287 | 2,676,988 (2%) | 0% | 6.3 | 633,814 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 13 Feb 2025 | 100,287 | 2,576,701 (2%) | 0% | 8.4 | 846,422 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Feb 2025 | 158,921 | 2,735,622 (2%) | 0% | 6.3 | 1,004,381 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 13 Feb 2025 | 158,921 | 2,576,701 (2%) | 0% | 8.5 | 1,344,472 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Feb 2025 | 211,160 | 2,787,861 (2%) | 0% | 6.3 | 1,334,531 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 13 Feb 2025 | 211,160 | 2,576,701 (2%) | 0% | 8.5 | 1,794,860 | Common Stock |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 100,287 | 655,268 | - | - | Stock Option (right to buy) | |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 158,921 | 496,347 | - | - | Stock Option (right to buy) | |
| Chad M. Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 211,160 | 285,187 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.98 per share. | 18 Nov 2024 | 248 | 154,330 (0%) | 0% | 5.0 | 1,235 | Common Stock |
| Susan Bobulsky | Chief Commercial Officer, MRD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 08 Oct 2024 | 5,000 | 253,290 (0%) | 0% | 2.0 | 9,900 | Common Stock |
| Stacy L. Taylor | SVP and General Counsel | 22 Aug 2024 | 26,922 | 139,365 (0%) | 0% | 4.5 | 121,079 | Common Stock | |
| Kyle Piskel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 31,260 | 154,578 (0%) | 0% | 0 | Common Stock | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 12 Mar 2024 | 15,000 | 169,296 (0%) | 0% | 0.8 | 12,600 | Common Stock |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Michael J. Pellini | Director | 04 Mar 2024 | 31,328 | 54,296 (0%) | 0% | 0 | Common Stock | ||
| Michael J. Pellini | Director | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | ||
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 154,296 (0%) | 0% | 0 | Common Stock | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 107,296 (0%) | 0% | 0 | Common Stock | |
| Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 51,955 (0%) | 0% | 0 | Common Stock | |
| Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Chad Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 2,625,374 (2%) | 0% | 0 | Common Stock | |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 42,794 | 2,576,701 (2%) | 0% | 3.4 | 146,783 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 5,879 | 2,619,495 (2%) | 0% | 3.4 | 20,224 | Common Stock |
| Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 175,000 | 511,824 (0%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 04 Mar 2024 | 13,490 | 472,754 (0%) | 0% | 3.6 | 48,024 | Common Stock |
| Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 25,580 | 486,244 (0%) | 0% | 3.4 | 87,739 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 1,021,180 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 99,976 | 268,445 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 12,887 | 255,558 (0%) | 0% | 3.4 | 44,202 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 1,813 | 253,745 (0%) | 0% | 3.4 | 6,237 | Common Stock |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 10,746 | 346,059 (0%) | 0% | 3.4 | 36,859 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 132,979 | 356,805 (0%) | 0% | 0 | Common Stock | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 18,644 | 327,415 (0%) | 0% | 3.4 | 64,135 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 43,740 | 131,045 (0%) | 0% | 0 | Common Stock | |
| Kyle Piskel | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 7,727 | 123,318 (0%) | 0% | 3.4 | 26,504 | Common Stock |
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 60,010 | 60,010 | - | - | Stock Option (right to buy) | ||
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 39,990 | 179,668 (0%) | 0% | 0 | Common Stock | ||
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 6,609 | 166,287 (0%) | 0% | 3.4 | 22,735 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 6,772 | 172,896 (0%) | 0% | 3.4 | 23,228 | Common Stock | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 6,975 | 248,290 (0%) | 0% | 3.4 | 23,994 | Common Stock |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 6,016 | 255,265 (0%) | 0% | 3.4 | 20,635 | Common Stock |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 132,979 | 261,281 (0%) | 0% | 0 | Common Stock | |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 57,235 (0%) | 0% | 0 | Common Stock | |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 147,790 | 547,009 (0%) | 0% | 0 | Common Stock | |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 15,456 | 531,553 (0%) | 0% | 3.4 | 53,169 | Common Stock |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 13 Dec 2023 | 100,000 | 122,968 (0%) | 0% | 0.8 | 84,000 | Common Stock |
| Nitin Sood | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 6.78 per share. | 07 Aug 2023 | 5,652 | 225,358 (0%) | 0% | 6.8 | 38,321 | Common Stock |
| Nitin Sood | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 07 Aug 2023 | 10,550 | 214,808 (0%) | 0% | 6.5 | 68,997 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.30 per share. | 20 Jun 2023 | 134,961 | 534,180 (0%) | 0% | 7.3 | 985,215 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2023 | 134,961 | 447,868 | - | - | Stock Option (right to buy) | |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 20 Jun 2023 | 64,961 | 399,219 (0%) | 0% | 8.1 | 528,783 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 20 Jun 2023 | 70,000 | 464,180 (0%) | 0% | 8.1 | 569,800 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 15 Jun 2023 | 55,672 | 399,219 (0%) | 0% | 8.5 | 474,882 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,328 | 582,829 | - | - | Stock Option (right to buy) | |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 15 Jun 2023 | 14,328 | 399,219 (0%) | 0% | 8.5 | 122,218 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.30 per share. | 15 Jun 2023 | 14,328 | 413,547 (0%) | 0% | 7.3 | 104,594 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.16 per share. | 02 Jun 2023 | 38,000 | 454,891 (0%) | 0% | 7.2 | 272,080 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.63 per share. | 10 Apr 2023 | 2,308 | 175,361 (0%) | 0% | 8.6 | 19,918 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 10 Apr 2023 | 817 | 177,669 (0%) | 0% | 8.5 | 6,945 | Common Stock |
| Leslie L. Trigg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 25,907 (0%) | 0% | 0 | Common Stock | |
| Leslie L. Trigg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Kevin T. Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | |
| Kevin T. Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Michael J. Pellini | Director | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | ||
| Michael J. Pellini | Director | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | ||
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 75,968 (0%) | 0% | 0 | Common Stock | |
| Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Chad Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 354,610 | 2,270,764 (1%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,979 | 359,492 (0%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 22,668 | 336,824 (0%) | 0% | 8.6 | 194,265 | Common Stock |
| Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 354,610 | 666,570 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 128,599 | 128,599 | - | - | Stock Option (right to buy) | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 85,697 | 175,285 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 6,816 | 168,469 (0%) | 0% | 8.6 | 58,413 | Common Stock |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,979 | 235,575 (0%) | 0% | 0 | Common Stock | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 11,749 | 223,826 (0%) | 0% | 8.6 | 100,689 | Common Stock |
| Kyle Piskel | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 3,300 | 87,793 (0%) | 0% | 8.6 | 28,281 | Common Stock |
| Kyle Piskel | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 06 Mar 2023 | 229 | 87,564 (0%) | 0% | 8.6 | 1,965 | Common Stock |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 43,735 | 91,093 (0%) | 0% | 0 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 13,387 | 139,678 (0%) | 0% | 8.6 | 115,128 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 85,697 | 158,556 (0%) | 0% | 0 | Common Stock | ||
| Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 5,491 | 153,065 (0%) | 0% | 8.6 | 47,058 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 128,599 | 128,599 | - | - | Stock Option (right to buy) | ||
| R Mark Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 88,652 | 202,170 (0%) | 0% | 0 | Common Stock | |
| R Mark Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 133,033 | 133,033 | - | - | Stock Option (right to buy) | |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.60 per share. | 06 Mar 2023 | 17,155 | 178,486 (0%) | 0% | 8.6 | 147,533 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 6,529 | 195,641 (0%) | 0% | 8.6 | 55,954 | Common Stock |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 25,907 (0%) | 0% | 0 | Common Stock | |
| Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Nitin Sood | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,979 | 247,484 (0%) | 0% | 0 | Common Stock | |
| Nitin Sood | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 8.60 per share. | 06 Mar 2023 | 9,813 | 231,010 (0%) | 0% | 8.6 | 84,392 | Common Stock |
| Nitin Sood | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 6,661 | 240,823 (0%) | 0% | 8.6 | 57,085 | Common Stock |
| Nitin Sood | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 118,203 | 492,891 (0%) | 0% | 0 | Common Stock | |
| Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 177,377 | 177,377 | - | - | Stock Option (right to buy) | |
| Robert M. Hershberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 53,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert M. Hershberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 02 Feb 2023 | 53,000 | 61,193 (0%) | 0% | 0.5 | 23,850 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 09 Jan 2023 | 2,130 | 113,518 (0%) | 0% | 8.6 | 18,275 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 09 Jan 2023 | 995 | 115,648 (0%) | 0% | 8.5 | 8,458 | Common Stock |
| Kyle Piskel | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.87 per share. | 16 Nov 2022 | 307 | 47,358 (0%) | 0% | 8.9 | 2,723 | Common Stock |
| Nitin Sood | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 01 Nov 2022 | 31,066 | 114,505 (0%) | 0% | 8 | 248,528 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.61 per share. | 07 Oct 2022 | 841 | 118,927 (0%) | 0% | 7.6 | 6,400 | Common Stock |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.13 per share. | 07 Oct 2022 | 2,284 | 116,643 (0%) | 0% | 7.1 | 16,285 | Common Stock |
| Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 597,157 | 597,157 | - | - | Stock Option (Right to Buy) | |
| Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 374,688 | 374,688 (0%) | 0% | 0 | Common Stock | |
| Lance Baldo | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 08 Mar 2022 | 3,350 | 17,171 (0%) | 0% | 11.4 | 38,291 | Common Stock |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 11.44 per share. | 08 Mar 2022 | 3,582 | 89,588 (0%) | 0% | 11.4 | 40,978 | Common Stock |
| Stacy L. Taylor | SVP and General Counsel | 08 Mar 2022 | 2,387 | 72,859 (0%) | 0% | 11.4 | 27,307 | Common Stock | |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 07 Mar 2022 | 500 | 1,930,469 (1%) | 0% | 12.2 | 6,110 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 07 Mar 2022 | 14,815 | 1,930,969 (1%) | 0% | 6.3 | 93,631 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 07 Mar 2022 | 14,815 | 1,916,154 (1%) | 0% | 11.4 | 168,595 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 07 Mar 2022 | 14,815 | 1,930,969 (1%) | 0% | 6.3 | 93,631 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 11.53 per share. | 07 Mar 2022 | 14,315 | 1,916,154 (1%) | 0% | 11.5 | 165,052 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 14,815 | 755,555 | - | - | Stock Option (Right to Buy) | |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 14,815 | 770,370 | - | - | Stock Option (Right to Buy) | |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 14,815 | 785,185 | - | - | Stock Option (Right to Buy) | |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 07 Mar 2022 | 14,815 | 1,916,154 (1%) | 0% | 12.5 | 184,595 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 07 Mar 2022 | 14,815 | 1,930,969 (1%) | 0% | 6.3 | 93,631 | Common Stock |
| Lance Baldo | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 07 Mar 2022 | 2,373 | 20,521 (0%) | 0% | 12.0 | 28,500 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,424 | 1,916,154 (1%) | 0% | 12.0 | 53,132 | Common Stock |
| Chad Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 247,117 | 1,920,578 (1%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,613 | 226,513 (0%) | 0% | 12.0 | 55,402 | Common Stock |
| Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 185,338 | 231,126 (0%) | 0% | 0 | Common Stock | |
| Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 463,344 | 463,344 | - | - | Stock Option (Right to Buy) | |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 617,792 | 617,792 | - | - | Stock Option (Right to Buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,517 | 311,960 (0%) | 0% | 12.0 | 54,249 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 247,117 | 316,477 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 185,338 | 185,338 | - | - | Stock Option (Right to Buy) | |
| Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 74,135 | 94,739 (0%) | 0% | 0 | Common Stock | |
| Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 1,569 | 93,170 (0%) | 0% | 12.0 | 18,844 | Common Stock |
| Sharon Benzeno | Chief Business Development Off | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 2,670 | 102,596 (0%) | 0% | 12.0 | 32,067 | Common Stock |
| Sharon Benzeno | Chief Business Development Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 82,372 | 105,266 (0%) | 0% | 0 | Common Stock | |
| Sharon Benzeno | Chief Business Development Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 205,931 | 205,931 | - | - | Stock Option (Right to Buy) | |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 102,965 | 102,965 | - | - | Stock Option (Right to Buy) | |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 41,186 | 47,885 (0%) | 0% | 0 | Common Stock | |
| Kyle Piskel | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 220 | 47,665 (0%) | 0% | 12.0 | 2,642 | Common Stock |
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 1,569 | 75,246 (0%) | 0% | 12.0 | 18,844 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 154,448 | 154,448 | - | - | Stock Option (Right to Buy) | ||
| Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 61,779 | 76,815 (0%) | 0% | 0 | Common Stock | ||
| R Mark Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 185,338 | 185,338 | - | - | Stock Option (Right to Buy) | |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 1,244 | 123,724 (0%) | 0% | 12.0 | 14,940 | Common Stock |
| R Mark Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 74,135 | 124,968 (0%) | 0% | 0 | Common Stock | |
| Nitin Sood | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 65,898 | 163,111 (0%) | 0% | 0 | Common Stock | |
| Nitin Sood | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 164,745 | 164,745 | - | - | Stock Option (Right to Buy) | |
| R Mark Adams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.32 per share. | 07 Jan 2022 | 1,021 | 50,833 (0%) | 0% | 23.3 | 23,810 | Common Stock |
| Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 22 Dec 2021 | 10,000 | 31,604 (0%) | 0% | 7.3 | 72,700 | Common Stock |
| Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2021 | 10,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Dec 2021 | 10,000 | 21,604 (0%) | 0% | 30 | 300,000 | Common Stock |
| Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 15,338 | 15,036 (0%) | 0% | 30 | 460,140 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 5,208 | 30,374 (0%) | 0% | 7.8 | 40,622 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 10,130 | 25,166 (0%) | 0% | 6.6 | 66,352 | Common Stock | |
| Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 5,208 | 17,709 | - | - | Stock Option (Right to Buy) | ||
| Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 10,130 | 5,313 | - | - | Stock Option (Right to Buy) | ||
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.05 per share. | 17 Nov 2021 | 3,700 | 69,360 (0%) | 0% | 32.1 | 118,585 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 300 | 284,800 | - | - | Stock Option (Right to Buy) | |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 3,700 | 285,100 | - | - | Stock Option (Right to Buy) | |
| Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.36 per share. | 17 Nov 2021 | 300 | 69,360 (0%) | 0% | 31.4 | 9,408 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 300 | 69,660 (0%) | 0% | 6.6 | 1,965 | Common Stock |
| Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 3,700 | 73,060 (0%) | 0% | 6.6 | 24,235 | Common Stock |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 9,592 | 9,592 | - | - | Stock Option (Right to Buy) | |
| Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 3,837 | 6,699 (0%) | 0% | 0 | Common Stock |